Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT – Get Free Report) has been given a consensus recommendation of “Buy” by the four ratings firms that are presently covering the firm, Marketbeat reports. Four investment analysts have rated the stock with a buy rating. The average twelve-month target price among brokerages that have issued ratings on the stock […]